Ashley N. Morphey

A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma

Michael L. Wang, R. Orlowski, Lei Feng, 2019, Blood Cancer Journal.

Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Patients with Posttransplant Myeloma

R. Orlowski, Q. Bashir, M. Qazilbash, 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I/Ib study of carfilzomib and panobinostat with or without dexamethasone in patients with relapsed/refractory multiple myeloma

R. Orlowski, B. Amini, Z. Berková, 2020, Haematologica.

Update on a Phase II Study of Ixazomib with Lenalidomide As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma

R. Orlowski, Q. Bashir, M. Qazilbash, 2017 .

Updated Results of a Phase II Study of Lenalidomide-Elotuzumab As Maintenance Therapy Post-Autologous Stem Cell Transplant (AuSCT) in Patients (Pts) with Multiple Myeloma (MM)

R. Orlowski, B. Amini, Sheeba K. Thomas, 2018, Blood.

Preliminary Results of a Phase II Study of Lenalidomide-Elotuzumab As Maintenance Therapy Post-Autologous Stem Cell Transplant in Patients with Multiple Myeloma

R. Orlowski, B. Amini, Sheeba K. Thomas, 2017 .